Terms: = Bone cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Treatment
31 results:
1. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
Banu MA; Raza SM; Amini M; Seaman S; Rubino F; Snyder R; Patel S; DeMonte F; Conley AP
Neurosurg Focus; 2024 May; 56(5):E15. PubMed ID: 38691867
[TBL] [Abstract] [Full Text] [Related]
2. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
3. The medial transorbital approach in cranioendoscopic skull base tumor resections for locally advanced tumors.
Scholfield DW; Levyn H; Tabar VS; Ganly I; Della Rocca D; Cohen MA
J Clin Neurosci; 2024 Jan; 119():198-204. PubMed ID: 38134571
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features of five cases of CIC::DUX4 positive sarcomas, including literature review.
Rekhi B; Rumdee R; Shetty O
Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
[TBL] [Abstract] [Full Text] [Related]
5. Ovarian epithelioid malignant peripheral nerve sheath tumor with EWSR1-CREM fusion: A case report and literature review.
Li S; Hong R; Wang X; Yang J
Int J Gynaecol Obstet; 2023 Nov; 163(2):521-527. PubMed ID: 37151162
[TBL] [Abstract] [Full Text] [Related]
6. Poorly Differentiated Chordoma of the Clivus With Loss of smarcb1 Expression in a Pediatric Patient: A Case Report.
Yasue S; Ozeki M; Endo S; Kanayama T; Suzui N; Nakamura S; Kishimoto K; Kosaka Y; Miyazaki T; Demizu Y; Soejima T; Kawamura A; Ohnishi H
J Pediatr Hematol Oncol; 2022 Nov; 44(8):465-470. PubMed ID: 35091519
[TBL] [Abstract] [Full Text] [Related]
7. Emerging concepts in sinonasal tumor research.
Lopez DC; Wadley AE; London NR
Curr Opin Otolaryngol Head Neck Surg; 2022 Feb; 30(1):33-39. PubMed ID: 34958321
[TBL] [Abstract] [Full Text] [Related]
8. Evaluating the effects of duloxetine on prophylaxis of oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: A randomized double-blind placebo controlled clinical trial.
Rokhsareh S; Haghighi S; Tavakoli-Ardakani M
J Oncol Pharm Pract; 2023 Jan; 29(1):60-65. PubMed ID: 34738855
[TBL] [Abstract] [Full Text] [Related]
9. Skull Base Tumors: Neuropathology and Clinical Implications.
Bi WL; Santagata S
Neurosurgery; 2022 Mar; 90(3):243-261. PubMed ID: 34164689
[TBL] [Abstract] [Full Text] [Related]
10. Skin maculae, chronic diarrhea, cachexia, and splenomegaly-Late presentation of the first autochthonous case of visceral leishmaniasis in Tanzania.
Henke O; Mapendo PJ; Mremi A; Mmbaga LG; Pallangyo AE; Harbaum T; Mkwizu E
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008925. PubMed ID: 33444339
[TBL] [Abstract] [Full Text] [Related]
11. Local Control After Proton Therapy for Pediatric Chordoma.
Indelicato DJ; Rotondo RL; Mailhot Vega RB; Holtzman AL; Looi WS; Morris CG; Sandler ES; Aldana PR; Bradley JA
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1406-1413. PubMed ID: 33253819
[TBL] [Abstract] [Full Text] [Related]
12. [Chordoma: is there a molecular basis for diagnosis and treatment?].
Scheipl S; Igrec J; Leithner A; Smolle M; Haybäck J; Liegl B
Pathologe; 2020 Mar; 41(2):153-162. PubMed ID: 32100085
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma.
Kowalik A; Jurkowska M; Mierzejewska E; Ługowska I; Gos A; Szumera-Ciećkiewicz A; Zięba S; Koseła-Paterczyk H; van der Oord J; Dębiec-Rychter M; Szamotulska K; Siedlecki J; Rutkowski P
Melanoma Res; 2020 Aug; 30(4):348-357. PubMed ID: 32073511
[TBL] [Abstract] [Full Text] [Related]
14. smarcb1-Deficient Sinonasal Carcinoma: Systematic Review and Case Report.
Parsel SM; Jawad BA; McCoul ED
World Neurosurg; 2020 Apr; 136():305-310. PubMed ID: 32001406
[TBL] [Abstract] [Full Text] [Related]
15. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
[TBL] [Abstract] [Full Text] [Related]
16. treatment of dedifferentiated chordoma: a retrospective study from a large volume cancer center.
Nachwalter RN; Rothrock RJ; Katsoulakis E; Gounder MM; Boland PJ; Bilsky MH; Laufer I; Schmitt AM; Yamada Y; Higginson DS
J Neurooncol; 2019 Sep; 144(2):369-376. PubMed ID: 31338785
[TBL] [Abstract] [Full Text] [Related]
17. Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family.
Chien YW; Hsieh TH; Chu PY; Hsieh SM; Liu ML; Lee JC; Liu YR; Ku JW; Kao YC
Genes Chromosomes Cancer; 2019 Nov; 58(11):809-814. PubMed ID: 31334571
[TBL] [Abstract] [Full Text] [Related]
18. Future directions in soft tissue sarcoma treatment.
Hall F; Villalobos V; Wilky B
Curr Probl Cancer; 2019 Aug; 43(4):300-307. PubMed ID: 31229264
[TBL] [Abstract] [Full Text] [Related]
19. Primary pseudomyogenic hemangioendothelioma of bone: case report and review of the literature.
Squillaci S; Pitino A; Spairani C; Rassu PC; Chiapuzzo E; Kutzner H
Pathologica; 2018 Sep; 110(2):96-101. PubMed ID: 30546145
[TBL] [Abstract] [Full Text] [Related]
20. Chemoradiotherapy for Unresectable ini1-negative Chordoma in a Child.
Miyahara H; Nodomi S; Umeda K; Itasaka S; Waki K; Imai T
J Pediatr Hematol Oncol; 2020 Jan; 42(1):65-68. PubMed ID: 30281526
[TBL] [Abstract] [Full Text] [Related]
[Next]